DK3288553T3 - Kombinationer af cannabinoider og n-acylethanolaminer - Google Patents

Kombinationer af cannabinoider og n-acylethanolaminer Download PDF

Info

Publication number: DK3288553T3
Authority: DK; Denmark
Prior art keywords: acylethanolamines; cannabinoids; combinations
Prior art date: 2015-04-29

Application number

DK16786064.2T

Other languages

English (en)

Inventor

Ascher Shmulewitz

Ephraim Brener

Elran Haber

Original Assignee

Scisparc Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-04-29

Filing date

2016-04-19

Publication date

2023-01-23

2016-04-19 Application filed by Scisparc Ltd filed Critical Scisparc Ltd

2023-01-23 Application granted granted Critical

2023-01-23 Publication of DK3288553T3 publication Critical patent/DK3288553T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Natural Medicines & Medicinal Plants (AREA)
Psychiatry (AREA)
Addiction (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Rheumatology (AREA)
Medical Informatics (AREA)
Biotechnology (AREA)
Botany (AREA)
Alternative & Traditional Medicine (AREA)
Microbiology (AREA)
Mycology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyrane Compounds (AREA)
Medicinal Preparation (AREA)
Medicines Containing Plant Substances (AREA)

DK16786064.2T 2015-04-29 2016-04-19 Kombinationer af cannabinoider og n-acylethanolaminer DK3288553T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201562154144P	2015-04-29	2015-04-29
PCT/IL2016/050414 WO2016174661A1 (en)	2015-04-29	2016-04-19	Combinations of cannabinoids and n-acylethanolamines

Publications (1)

Publication Number	Publication Date
DK3288553T3 true DK3288553T3 (da)	2023-01-23

Family

ID=57199061

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK16786064.2T DK3288553T3 (da)	2015-04-29	2016-04-19	Kombinationer af cannabinoider og n-acylethanolaminer

Country Status (12)

Country	Link
US (7)	US11234956B2 (da)
EP (2)	EP3288553B1 (da)
JP (2)	JP6938465B2 (da)
CN (2)	CN116549437A (da)
AU (3)	AU2016254685B2 (da)
CA (1)	CA2984088C (da)
DK (1)	DK3288553T3 (da)
ES (1)	ES2935605T3 (da)
IL (2)	IL291864A (da)
MA (1)	MA41997A (da)
PL (1)	PL3288553T3 (da)
WO (1)	WO2016174661A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20210052478A1 (en) *	2018-01-05	2021-02-25	Altus Labs, Llc	Personal care compositions
EP3746068A4 (en) *	2018-01-29	2021-11-03	Evero	COMPOSITIONS AND METHODS OF TREATMENT OF OBSTRUCTIVE SLEEP APNEA
MX2020010424A (es) *	2018-04-03	2021-01-15	Pure Green Pharmaceuticals Inc	Comprimido o composicion que contiene n-acil etanolamina y cannabinoides.
WO2020160452A1 (en) *	2019-02-01	2020-08-06	Tess Ventures, Inc.	Combining serms, sarms, and cannabinoids for improving safety and efficacy of endocrine therapies
AU2020260090C9 (en) *	2019-04-15	2023-08-31	Metagenics LLC	Novel hemp and PEA formulation and its use
MX2021012892A (es) *	2019-04-23	2021-11-17	Scisparc Ltd	Composiciones y metodos para potenciar derivados de 4-aminofenoles.
EP3965789A4 (en) *	2019-05-07	2023-01-25	Ojai Energetics PBC	PROCEDURE FOR OPTIMIZING CANNABINOID DOSAGE DETERMINATION
EP4017486A4 (en) *	2019-08-19	2023-09-20	Buzzelet Development And Technologies Ltd	COMPOSITIONS FOR TREATING A CONDITION CHARACTERIZED BY ANANDAMID DEFICIENCY AND USES THEREOF
EP3838346A1 (en) *	2019-12-20	2021-06-23	Chemo Research SL	Soft gelatin capsules comprising palmitoylethanolamide and alpha-lipoic acid
WO2021141963A1 (en)	2020-01-10	2021-07-15	Pacira Pharmaceuticals, Inc.	Treatment of pain by subarachnoid administration of sustained-release liposomal anesthetic compositions
US20230130180A1 (en)	2020-01-10	2023-04-27	Pacira Pharmaceuticals, Inc.	Treatment of pain by administration of sustained-release liposomal anesthetic compositions
US11273122B2 (en)	2020-02-11	2022-03-15	Therese Mainella	Combination of cannabis, derivatives thereof and additives in oral care compositions
US11918688B2 (en)	2021-01-11	2024-03-05	Pacira Pharmaceuticals, Inc.	Treatment of hip pain with sustained-release liposomal anesthetic compositions
US20230000936A1 (en) *	2021-06-30	2023-01-05	Demetrix, Inc.	Alleviation of itching sensations using cannabinoid compounds
WO2023200906A1 (en)	2022-04-12	2023-10-19	Shackelford Pharma Inc.	Treatment of seizure disorders
US11918565B1 (en)	2022-11-03	2024-03-05	Pacira Pharmaceuticals, Inc.	Treatment of post-operative pain via sciatic nerve block with sustained-release liposomal anesthetic compositions
US12226610B2 (en)	2022-11-03	2025-02-18	Pacira Pharmaceuticals, Inc.	Treatment of pain associated with total knee arthroplasty with sustained-release liposomal anesthetic compositions
WO2024124354A1 (en) *	2022-12-16	2024-06-20	Aima Inc.	Compositions and methods for treating or preventing pain or other disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1082292B1 (en) *	1998-05-29	2005-09-28	Neurosciences Research Foundation	Control of pain with endogenous cannabinoids
US6949582B1 (en) *	1999-05-27	2005-09-27	Wallace Walter H	Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment
GB2394894B (en) *	2002-11-04	2005-08-31	G W Pharma Ltd	New use for pharmaceutical composition
EP1917007A2 (en) *	2005-07-14	2008-05-07	Rheoscience A/S	Inhibitors of anorexic lipid hydrolysis for the treatment of eating disorders
GB2432312A (en) *	2005-11-01	2007-05-23	Gw Pharma Ltd	Pharmaceutical compositions for the treatment of pain
PL2796129T3 (pl) *	2009-09-07	2015-11-30	Epitech Group S P A	Kompozycja zawierająca palmitoiloetanoloamid poddany ultramikronizacji
GB2514054A (en) *	2011-09-29	2014-11-12	Gw Pharma Ltd	A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
EP2719375A1 (en) *	2012-10-10	2014-04-16	Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.	Cannabinoids for the treatment of cancers dependent on hedgehog mechanisms

2016
- 2016-04-19 AU AU2016254685A patent/AU2016254685B2/en active Active
- 2016-04-19 IL IL291864A patent/IL291864A/en unknown
- 2016-04-19 PL PL16786064.2T patent/PL3288553T3/pl unknown
- 2016-04-19 ES ES16786064T patent/ES2935605T3/es active Active
- 2016-04-19 MA MA041997A patent/MA41997A/fr unknown
- 2016-04-19 EP EP16786064.2A patent/EP3288553B1/en active Active
- 2016-04-19 CN CN202310678191.6A patent/CN116549437A/zh active Pending
- 2016-04-19 JP JP2018507796A patent/JP6938465B2/ja active Active
- 2016-04-19 CN CN201680024534.5A patent/CN107530317A/zh active Pending
- 2016-04-19 EP EP22215663.0A patent/EP4193993A3/en active Pending
- 2016-04-19 WO PCT/IL2016/050414 patent/WO2016174661A1/en active Application Filing
- 2016-04-19 US US15/570,118 patent/US11234956B2/en active Active
- 2016-04-19 DK DK16786064.2T patent/DK3288553T3/da active
- 2016-04-19 CA CA2984088A patent/CA2984088C/en active Active
2017
- 2017-10-24 IL IL255238A patent/IL255238B/en unknown
2019
- 2019-08-30 US US16/557,379 patent/US11207290B2/en active Active
- 2019-10-01 US US16/589,611 patent/US20200030281A1/en not_active Abandoned
- 2019-10-10 US US16/598,029 patent/US11197845B2/en active Active
2021
- 2021-03-30 JP JP2021057991A patent/JP2021107401A/ja active Pending
- 2021-07-19 AU AU2021206784A patent/AU2021206784B2/en active Active
- 2021-08-27 US US17/459,583 patent/US20210393577A1/en active Pending
- 2021-11-12 US US17/524,942 patent/US20220071948A1/en not_active Abandoned
- 2021-11-12 US US17/525,046 patent/US20220071949A1/en active Pending
2023
- 2023-10-17 AU AU2023251426A patent/AU2023251426A1/en active Pending

Also Published As

Publication number	Publication date
ES2935605T3 (es)	2023-03-08
CA2984088A1 (en)	2016-11-03
IL255238B (en)	2022-05-01
JP6938465B2 (ja)	2021-09-22
WO2016174661A1 (en)	2016-11-03
CN116549437A (zh)	2023-08-08
CA2984088C (en)	2024-04-09
US20220071948A1 (en)	2022-03-10
US20200022946A1 (en)	2020-01-23
AU2021206784B2 (en)	2023-07-20
JP2021107401A (ja)	2021-07-29
US20180078523A1 (en)	2018-03-22
PL3288553T3 (pl)	2023-03-20
US11207290B2 (en)	2021-12-28
US11197845B2 (en)	2021-12-14
US20200030281A1 (en)	2020-01-30
AU2016254685A1 (en)	2017-11-09
EP4193993A3 (en)	2023-07-19
US20210393577A1 (en)	2021-12-23
EP3288553B1 (en)	2022-12-28
AU2016254685B2 (en)	2021-04-22
US20200038367A1 (en)	2020-02-06
EP3288553A1 (en)	2018-03-07
EP4193993A2 (en)	2023-06-14
AU2021206784A1 (en)	2021-08-12
AU2023251426A1 (en)	2023-11-09
IL291864A (en)	2022-06-01
EP3288553A4 (en)	2018-12-26
US20220071949A1 (en)	2022-03-10
IL255238A0 (en)	2017-12-31
US11234956B2 (en)	2022-02-01
JP2018514589A (ja)	2018-06-07
CN107530317A (zh)	2018-01-02
MA41997A (fr)	2021-03-31

Publication	Publication Date	Title
DK3288553T3 (da)	2023-01-23	Kombinationer af cannabinoider og n-acylethanolaminer
DK3289168T3 (da)	2019-12-16	Forsegling og aktivering af borehul
DK3317284T3 (da)	2020-01-13	Benzoxazepin-oxazolidinonforbindelser og fremgangsmåder til anvendelse
DK3212189T3 (da)	2020-10-26	Substituerede chromaner og fremgangsmåde til anvendelse deraf
DK3368534T3 (da)	2021-02-15	Valbenazin-ditosylat og polymorfer deraf
DK3137169T3 (da)	2022-02-14	Hæmmere af lysin-specifik demethylase-1
DK3134530T3 (da)	2019-09-09	Behandling af hyperbilirubinæmi
DK3102576T3 (da)	2019-07-22	Dihydropyrrolopyridininhibitorer af ror-gamma
DK3160470T3 (da)	2022-10-24	Analoger af pridopidin, fremstilling og anvendelse heraf
DK3160956T3 (da)	2020-08-31	Inhibitorer af lysin-specifik demethylase-1
DK3511319T3 (da)	2023-07-31	Hæmmere af lysinspecifik demethylase-1
DK3144001T3 (da)	2021-11-15	Sammensætninger af selenoorganiske forbindelser og fremgangsmåder til anvendelse deraf
DK3364958T3 (da)	2023-04-11	Modulatorer af sestrin-gator2-interaktion og anvendelser deraf
DK3099800T3 (da)	2021-01-11	Ekspression og oprensning af crm197 og beslægtede proteiner
DK3265641T3 (da)	2020-03-16	Stigørenhed og fremgangsmåde
DK3307267T3 (da)	2019-07-01	Behandling af multipel sklerose
DK3265126T3 (da)	2021-09-13	Kombinationsformulering af tesofensin og metoprolol
DK3283210T3 (da)	2021-11-22	Fremgangsmåde
DK3319609T3 (da)	2022-08-22	Sammensætninger og fremgangsmåder til anvendelse af antibakterielle lægemiddelkombinationer
DK3374659T3 (da)	2021-05-25	Skivebremse og sæt af bremseklodser
DK3128005T3 (da)	2021-06-28	Sirp-alfa-variantkonstruktioner og anvendelser deraf
DK3390422T3 (da)	2023-11-27	Krystalformer af lnt
DK3288379T3 (da)	2022-02-07	Peptidsammensætninger og anvendelsesmåder
DK3368044T3 (da)	2021-09-13	Behandling af hepatisk steatose-relateret oligo-ovulation
DK3204352T3 (da)	2020-09-28	Hæmmere af lysin-gingipain